Combating antimicrobial resistance: Antimicrobial stewardship program in Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 45, Issue 2, 2012, Pages 79-89

  Tseng, Shu Hui ^a,b   Lee, Chun Ming ^c,d   Lin, Tzou Yien ^e   Chang, Shan Chwen ^f   Chuang, Yin Ching ^g   Yen, Muh Yong ^h   Hwang, Kao Pin ⁱ   Leu, Hsieh Shong ^j,k   Yen, Che Chieh ^a   Chang, Feng Yee ^a,l  

^a Centers for Disease Control   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^e CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^g CHI MEI MEDICAL CENTER   (Taiwan)

^h NATIONAL YANG MING UNIVERSITY   (Taiwan)

ⁱ CHINA MEDICAL UNIVERSITY   (Taiwan)

^j CHANG GUNG UNIVERSITY   (Taiwan)

^k CHANG GUNG UNIVERSITY   (Taiwan)

^l NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

more..

Author keywords

Antimicrobial resistance; Antimicrobial stewardship program(ASP); Healthcare associated infection (HAI); Multi drug resistant organisms(MDROs)

Indexed keywords

ANTIINFECTIVE AGENT;

ACCREDITATION; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; EVIDENCE BASED MEDICINE; GOVERNMENT; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; MULTIDRUG RESISTANCE; NONHUMAN; REVIEW; TAIWAN; UNITED STATES; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HEALTH POLICY; HUMANS; TAIWAN;

EID: 84859846731     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2012.03.007     Document Type: Review

References (58)

1. Boucher H.W., Talbot G.H., Bradley J.S., Edwards J.E., Gilbert D., Rice L.B., et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:1-12.
2. Kumarasamy K.K., Toleman M.A., Walsh T.R., Bagaria J., Butt F., Balakrishnan R., et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010, 10:597-602.
3. World Health Organization (WHO) Antimicrobial resistance and its global spread 2011, Available from:. http://www.who.int/world-health-day/en/index.html.
4. World Health Organization (WHO) WHO global strategy for containment of antimicrobial resistance Available from:. http://www.who.int/csr/resources/publications/drugresist/en/EGlobal_Strat.pdf.
5. Hwang K.P., Tang Y.F., Shen Y.H. Activity of ertapenem, ciprofloxacin, ceftriaxone, piperacillin-tazobactam, and ampicillin-sulbactam against 12 common clinical isolates of community-acquired bacteremia. J Microbiol Immunol Infect 2009, 42:433-438.
6. Lee C.M., Yeh S.C., Lim H.K., Liu C.P., Tseng H.K. High prevalence rate of multidrug resistance among nosocomial pathogens in the respiratory care center of a tertiary hospital. J Microbiol Immunol Infect 2009, 42:401-404.
7. Chen W.Y., Jang T.N., Huang C.H., Hsueh P.R. In vitro susceptibilities of aerobic and facultative anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center in Taiwan: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2002-2006. J Microbiol Immunol Infect 2009, 42:317-323.
8. Liu C.Y., Liao C.H., Chen Y.C., Chang S.C. Changing epidemiology of nosocomial bloodstream infections in 11 teaching hospitals in Taiwan between 1993 and 2006. J Microbiol Immunol Infect 2010, 43:416-429.
9. Lee C.Y., Chen P.Y., Huang F.L., Lin C.F. Microbiologic spectrum and susceptibility pattern of clinical isolates from the pediatric intensive care unit in a single medical center - 6 years' experience. J Microbiol Immunol Infect 2009, 42:160-165.
10. Chen P.L., Ko W.C. A continuous challenge from Gram-negative bacteria: more carbapenemases. J Microbiol Immunol Infect 2010, 43:351-353.
11. Tseng S.H., Lee C.M., Lin T.Y., Chang S.C., Chang F.Y. Emergence and spread of multi-drug resistant organisms: think globally and act locally. J Microbiol Immunol Infect 2011, 44:157-165.
12. Taiwan Centers for Disease Control Nosocomial infection control 2009, Available from:. http://www.cdc.gov.tw/ct.asp%3FxItem%3D7789%26ctNode%3D928%26mp%3D5.
13. Taiwan Centers for Disease Control Surveillance of noscomial infection 2009, Available from:. http://www.cdc.gov.tw/ct.asp%3FxItem%3D32212%26ctNode%3D1711%26mp%3D1.
14. Ansari F., Gray K., Nathwani D., Phillips G., Ogston S., Ramsay C., et al. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother 2003, 52:842-848.
15. Carling P., Fung T., Killion A., Terrin N., Barza M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 2003, 24:699-706.
16. Ruttimann S., Keck B., Hartmeier C., Maetzel A., Bucher H.C. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis 2004, 38:348-356.
17. Rahal J.J., Urban C., Segal-Maurer S. Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites. Clin Infect Dis 2002, 34:499-503.
18. Drew R.H. Antimicrobial stewardship programs: how to start and steer a successful program. J Manag Care Pharm 2009, 15:S18-S23.
19. American Society of Health-System Pharmacists A hospital pharmacist's guide to antimicrobial stewardship programs 2011, Available from:. http://onlinece.ashpadvantage.com/stewardship/stewardship-white-paper.pdf.
20. Dellit T.H., Owens R.C., McGowan J.E., Gerding D.N., Weinstein R.A., Burke J.P., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007, 44:159-177.
21. Lan C.K., Hsueh P.R., Wong W.W., Fung C.P., Lau Y.T., Yeung J.Y., et al. Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase-producing organisms. J Microbiol Immunol Infect 2003, 36:182-186.
22. MacDougall C., Polk R.E. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev 2005, 18:638-656.
23. Taiwan Centers for Disease Control Standard criteria of hospital accreditation 2011, Available from:. http://www.doh.gov.tw/CHT2006/DM/DM2.aspx%3Fnow_fod_list_no%3D11240%26class_no%3D472%26level_no%3D2.
24. Taiwan Centers for Disease Control Standard criteria of hospital infection control inspection 2011, Available from:. http://www.cdc.gov.tw/ct.asp%3FxItem%3D13464%26ctNode%3D1891%26mp%3D1.
25. Bureau of National Health Insurance Pay for performances 2011, Available from:. http://www.nhi.gov.tw/english/webdata.asp%3Fmenu%3D11%26menu_id%3D597%26webdata_id%3D3188.
26. Marrie T.J., Lau C.Y., Wheeler S.L., Wong C.J., Vandervoort M.K., Feagan B.G. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL study investigators. Community-acquired pneumonia intervention trial assessing Levofloxacin. JAMA 2000, 283:749-755.
27. Hsueh P.R., Ko W.C., Wu J.J., Lu J.J., Wang F.D., Wu H.Y., et al. Consensus statement on the adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in clinical microbiology laboratories in Taiwan. J Microbiol Immunol Infect 2010, 43:452-455.
28. Guidelines on antimicrobial therapy of pneumonia in adults in Taiwan, revised 2006. J Microbiol Immunol Infect 2007, 40:279-283.
29. Jan I.S., Cheng S.H., Hsu H.C., Hsueh P.R. Physicians' adherence to guidelines for empirical treatment of urinary tract infection in Taiwan. J Microbiol Immunol Infect 2007, 40:532-536.
30. Echols R.M., Kowalsky S.F. The use of an antibiotic order form for antibiotic utilization review: influence on physicians' prescribing patterns. J Infect Dis 1984, 150:803-807.
31. Glowacki R.C., Schwartz D.N., Itokazu G.S., Wisniewski M.F., Kieszkowski P., Weinstein R.A. Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance. Clin Infect Dis 2003, 37:59-64.
32. Soo Hoo G.W., Wen Y.E., Nguyen T.V., Goetz M.B. Impact of clinical guidelines in the management of severe hospital-acquired pneumonia. Chest 2005, 128:2778-2787.
33. Dunbar L.M., Wunderink R.G., Habib M.P., Smith L.G., Tennenberg A.M., Khashab M.M., et al. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis 2003, 37:752-760.
34. Nicolau D.P. Pharmacodynamic optimization of beta-lactams in the patient care setting. Crit Care 2008, 12(Suppl. 4):S2.
35. EARS-net Antimicrobial resistance surveillance in Europe 2009 Available from:. http://www.ecdc.europa.eu/en/activities/surveillance/EARS-Net/Pages/index.aspx.
36. Hidron A.I., Edwards J.R., Patel J., Horan T.C., Sievert D.M., Pollock D.A., et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008, 29:996-1011.
37. Nicolle L. Infection control programmes to contain antimicrobial resistance, 2001 Organization WH WHO/CDS/CSR/DRS/2001.7.
38. Center for Disease Control Campaign to prevent antimicromial resistance in healthcare settings. Fact sheet: 12 steps to prevent antimicrobial resistance among hospitallized adults 2010, Available from:. http://www.cdc.gov/drugresistance/healthcare/ha/12steps_HA.htm.
39. Boyce J.M., Pittet D. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep 2002, 51:1-45. quiz CE1-4.
40. Siegel J.D., Rhinehart E., Jackson M., Chiarello L. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007, 35:S65-164.
41. Rutala W.A., Weber D.J. HICPAC. Guideline for disinfection and sterilization in healthcare facilities, 2008 2008, Available from:. http://www.cdc.gov/ncidod/dhqp/pdf/guidelines/Disinfection_Nov_2008.pdf.
42. Sehulster L., Chinn R.Y. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003, 52:1-42.
43. Boyce J.M., Pittet D. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol 2002, 23:S3-40.
44. Pittet D., Boyce J.M. Hand hygiene and patient care: pursuing the Semmelweis legacy. Lancet Infect Dis 2001, 1:9-20.
45. Pittet D., Allegranzi B., Storr J. The WHO clean care is safer care programme: field-testing to enhance sustainability and spread of hand hygiene improvements. J Infect Public Health 2008, 1:4-10.
46. CDC Reduction in central line-associated bloodstream infections among patients in intensive care units-Pennsylvania, April 2001-March 2005. MMWR 2005, 54:1013-1016.
47. Pronovost P., Needham D., Berenholtz S., Sinopoli D., Chu H., Cosgrove S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006, 355:2725-2732.
48. Department of Health and Human Services Action plan to prevent healthcare-associated infections 2009, Available from:. http://www.hhs.gov/news/press/2009pres/01/20090106a.html.
49. Agency for Healthcare Research and Qualit AHRQ projects to prevent healthcare-associated infections 2010, Available from:. http://www.ahrq.gov/qual/haify10.pdf.
50. Michgen Health & Hospital Association MHA Keystone: Intensive Care Unit (ICU) 2010, Available from:. http://www.mhakeystonecenter.org/icu_overview.htm.
51. Vital signs: central line-associated blood stream infections-United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011, 60:243-248.
52. Render M.L., Hasselbeck R., Freyberg R.W., Hofer T.P., Sales A.E., Almenoff P.L. Reduction of central line infections in Veterans Administration intensive care units: an observational cohort using a central infrastructure to support learning and improvement. BMJ Qual Saf 2011.
53. O'Grady N.P., Alexander M., Burns L.A., Dellinger E.P., Garland J., Heard S.O., et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011, 52:e162-e193.
54. Gould C.V., Umscheid C.A., Agarwal R.K., Kuntz G., Pegues D.A. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol 2010, 31:319-326.
55. Tablan O.C., Anderson L.J., Besser R., Bridges C., Hajjeh R. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004, 53:1-36.
56. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., Jarvis W.R. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999, 20:250-278. quiz 79-80.
57. Taiwan F.D.A. Pharmaceutical affairs act 2005, Available from:. http://www.fda.gov.tw/files/people_laws/200507_Pharmaceutical%2520Affairs%2520Act.doc.
58. Taiwan CDC Communicable diseases and prevention 2010, Available from:. http://www.cdc.gov.tw/lp.asp%3FctNode%3D1807%26CtUnit%3D991%26BaseDSD%3D7%26mp%3D1.